Cargando…
Treating iPSC-Derived β Cells with an Anti-CD30 Antibody–Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation
Insulin-producing cells derived from induced pluripotent stem cells (iPSCs) are promising candidates for β cell replacement in type 1 diabetes. However, the risk of teratoma formation due to residual undifferentiated iPSCs contaminating the differentiated cells is still a critical concern for clinic...
Autores principales: | Pellegrini, Silvia, Zamarian, Valentina, Landi, Elisa, Cospito, Alessandro, Lombardo, Marta Tiffany, Manenti, Fabio, Citro, Antonio, Schiavo Lena, Marco, Piemonti, Lorenzo, Sordi, Valeria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456216/ https://www.ncbi.nlm.nih.gov/pubmed/36077097 http://dx.doi.org/10.3390/ijms23179699 |
Ejemplares similares
-
Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes
por: Pellegrini, Silvia, et al.
Publicado: (2022) -
Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I(−/−) iPSCs for β cell replacement
por: Chimienti, Raniero, et al.
Publicado: (2022) -
Differentiation of Sendai Virus-Reprogrammed iPSC into β Cells,
Compared with Human Pancreatic Islets and Immortalized β Cell
Line
por: Pellegrini, Silvia, et al.
Publicado: (2018) -
Pro-maturational Effects of Human iPSC-Derived Cortical Astrocytes upon iPSC-Derived Cortical Neurons
por: Hedegaard, Anne, et al.
Publicado: (2020) -
PITX2 gain-of-function mutation associated with atrial fibrillation alters mitochondrial activity in human iPSC atrial-like cardiomyocytes
por: Benzoni, Patrizia, et al.
Publicado: (2023)